NCT06650306

Brief Summary

To investigate the influence of Neuromediators expression in corneal stromal lenticules and corneal injury repair after small incision extraction

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
2mo left

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Oct 2024Jun 2026

First Submitted

Initial submission to the registry

October 16, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

October 18, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

October 21, 2024

Status Verified

October 1, 2024

Enrollment Period

1.7 years

First QC Date

October 16, 2024

Last Update Submit

October 18, 2024

Conditions

Keywords

Corneal NeuromediatorSoft contact lensesCorneal optical densityCorneal aberration

Outcome Measures

Primary Outcomes (1)

  • Corneal stromal lenticule Neuromediators

    Corneal neuromediators, including NGF(pg/mL), CGRP(pg/mL), SP(pg/mL), IGFBP-1(ng/mL), and MANF(pg/mL), which play pivotal roles in maintaining normal physiological functions of the cornea.

    baseline

Secondary Outcomes (2)

  • Corneal Aberration

    baseline

  • Corneal Densitometry

    baseline

Study Arms (3)

SCLs >10 years

high myopia patients who wear SCL more than 10 years before Small Incision Lenticule Extraction

Other: This study does not involve any interventions

SCLs ≤10 years

high myopia patients who wear SCL for 10 years or less before Small Incision Lenticule Extraction

Other: This study does not involve any interventions

NW

high myopia patients who have not worn SCLs before Small Incision Lenticule Extraction

Other: This study does not involve any interventions

Interventions

This study does not involve any interventions

NWSCLs >10 yearsSCLs ≤10 years

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients with high myopia who underwent SMILE surgery at Shanghai Tenth People's Hospital in Shanghai, China, between October 2020 and October 2023.

You may qualify if:

  • age ≥ 18 years with stable refraction for at least two years;
  • spherical equivalent (SE) \< -6.00 D;
  • corrected distance visual acuity of 20/20 or better;
  • no history of using rigid gas permeable lenses or orthokeratology (OK) lenses prior to examination

You may not qualify if:

  • \- a history of moderate to severe dry eye as well as any ocular or systemic disease that would contraindicate laser refractive surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

All samples were collected from participants with high myopia who underwent SMILE surgery. The VisuMax femtosecond laser system (Carl Zeiss Meditec, Jena, Germany) was utilized with the following settings: a repetition rate of 500 kHz, pulse energy of 150 nJ, intended cap thickness of 110-120 μm, and optical zone of 6.0-6.8 mm. A circumferential incision width of 2 mm was made for lenticule dissection and extraction. The surgical procedures were performed by a single experienced surgeon (Dr. Zou). Following the SMILE surgeries, corneal stromal lenticules were transferred to Eppendorf tubes and stored at -80°C. for subsequent analysis.

Central Study Contacts

Yuhao Shao, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 16, 2024

First Posted

October 21, 2024

Study Start

October 18, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

October 21, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations